We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$11.4B
AUM Growth
+$476M
Cap. Flow
-$300M
Cap. Flow %
-2.64%
Top 10 Hldgs %
22.33%
Holding
2,538
New
224
Increased
309
Reduced
1,136
Closed
102

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$24.1M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$21.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$13.2M
4
PATH icon
UiPath
PATH
+$10.4M
5
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$4.67M

Top Sells

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$20.7M
2
AAPL icon
Apple
AAPL
+$16M
3
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$15.6M
4
MSFT icon
Microsoft
MSFT
+$13M
5
WMB icon
Williams Companies
WMB
+$9.28M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Financials 13.29%
3 Healthcare 12.64%
4 Consumer Discretionary 11.46%
5 Industrials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRRX
2426
DELISTED
DURECT Corp
DRRX
$40K ﹤0.01%
2,453
-6,987
-74% -$122K
EGIO
2427
DELISTED
Edgio, Inc. Common Stock
EGIO
$39.1K ﹤0.01%
310
-892
-74% -$118K
GSKY
2428
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$39K ﹤0.01%
7,034
-20,765
-75% -$124K
ZIXI
2429
DELISTED
Zix Corporation
ZIXI
$34.9K ﹤0.01%
4,951
-16,824
-77% -$122K
LITS
2430
Lite Strategy Inc
LITS
$31.4M
$32.7K ﹤0.01%
575
-1,821
-76% -$117K
BDSI
2431
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$30.3K ﹤0.01%
8,451
-32,102
-79% -$113K
TECX
2432
Tectonic Therapeutic
TECX
$720M
$13.4K ﹤0.01%
125
-1,029
-89% -$122K
DTM icon
2433
DT Midstream
DTM
$13.9B
$12.1K ﹤0.01%
+314
New +$12.7K
SPB icon
2434
Spectrum Brands
SPB
$2.03B
$6.72K ﹤0.01%
79
– –
AMPY icon
2435
Amplify Energy
AMPY
$182M
$2.02K ﹤0.01%
499
– –
AA icon
2436
Alcoa
AA
$13.5B
– –
-70,612
Closed -$2.29M
ADVM
2437
DELISTED
Adverum Biotechnologies
ADVM
– –
-2,389
Closed -$236K
APYX icon
2438
Apyx Medical
APYX
$126M
– –
-14,882
Closed -$144K
ARTNA icon
2439
Artesian Resources
ARTNA
$362M
– –
-3,384
Closed -$133K
BDTX icon
2440
Black Diamond Therapeutics
BDTX
$121M
– –
-8,148
Closed -$198K
BEPC icon
2441
Brookfield Renewable
BEPC
$6.5B
– –
-47,570
Closed -$2.23M
BOLT icon
2442
Bolt Biotherapeutics
BOLT
$6.63M
– –
-300
Closed -$197K
CGNT icon
2443
Cognyte Software
CGNT
$675M
– –
-25,212
Closed -$701K
CIA icon
2444
Citizens
CIA
$199M
– –
-22,933
Closed -$133K
CODX
2445
Co-Diagnostics
CODX
$5.45M
– –
-99
Closed -$28.2K
CTO
2446
CTO Realty Growth
CTO
$819M
– –
-8,088
Closed -$140K
CTSO icon
2447
Cytosorbents Corp
CTSO
$23.3M
– –
-17,682
Closed -$153K
DADA
2448
DELISTED
Dada Nexus
DADA
– –
-1,049
Closed -$38.3K
DSP icon
2449
Viant Technology
DSP
$264M
– –
-5,000
Closed -$264K
FDMT icon
2450
4D Molecular Therapeutics
FDMT
$621M
– –
-4,083
Closed -$177K
96 97
98
99 100

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, MetLife Investment Management held 2,538 positions worth $11.4B, up 4.4% from $10.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management's Q2 2021 filing shows 224 new, 309 increased, 1,136 reduced and 102 closed positions. Its largest new stake was UiPath: 142,126 shares worth $9.65M. The largest sale was MPLX, an estimated $20.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q2 2021 buy was UiPath: 142,126 shares worth $9.65M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $24.1M increase.
  • MetLife Investment Management's biggest Q2 2021 reduction was Apple, cutting an estimated $16M.
  • MetLife Investment Management fully exited MPLX in Q2 2021, selling an estimated $20.7M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $11.4B portfolio in Q2 2021.
  • MetLife Investment Management opened 224 new positions and closed 102 in Q2 2021.
  • MetLife Investment Management's portfolio value rose 4.4% quarter-over-quarter to $11.4B.

Based on MetLife Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.